-
UK NICE Board approves changes to drug evaluation process
pharmaceutical-technology
March 20, 2017
The UK National Institute for Health and Care Excellence (NICE) board has approved changes to the drug evaluation process.
-
NICE backs use of Biogen’s Zinbryta for MS
pharmatimes
March 17, 2017
Eligible patients with multiple sclerosis should be able to get routine access to Biogen’s Zinbryta on the NHS in the next ...
-
Fantastic Returns on Rare Disease Drug Development
en-cphi
March 17, 2017
The growing interest of the pharmaceutical industry in rare disease drugs has not showed any sign of wane.
-
Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal viola
cphi-online
March 16, 2017
Dietary supplement products "misbranded" and unapproved new drugs being marketed with drug claims despite not being approved for any use.
-
US nod for Novartis’ breast cancer drug Kisqali
pharmatimes
March 15, 2017
Novartis’ selective cyclin-dependent kinase inhibitor Kisqali has been approved by the US Food and Drug Administration...
-
FDA grants orphan drug designation to Boehringer Ingelheim’s antibody BI 836858
pharmaceutical-technology
March 14, 2017
The US Food and Drug Administration (FDA) has granted orphan drug designation to Boehringer Ingelheim’s anti-CD33 ...
-
Johnson & Johnson says net price increase of its US drug portfolio was 3.5 percent last year
firstwordpharma
February 28, 2017
Johnson & Johnson on Monday released its 2016 transparency report, which showed that the list prices of its pharmaceutical products in the US rose by an average of 8.5 percent, compared with the year before.
-
Australia approves drug that can 'melt away' cancer cells
biospectrumasia
January 16, 2017
The drug was discovered and developed with scientists from US pharmaceutical companies AbbVie and Genentech, as part of an international collaboration with the Walter and Eliza Hall Institute